🇺🇸 FDA
Pipeline program

Iopofosine I 131

DCL-25-003

Phase 1 small_molecule active

Quick answer

Iopofosine I 131 for Breast Cancer is a Phase 1 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Cellectar Biosciences
Indication
Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials